Dr. Das is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street Grb 804
Massachusetts General Hospital
Boston, MA 02114Phone+1 617-726-5557Fax+1 617-724-2058
Education & Training
- Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2004 - 2005
- Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2002
- Harvard Medical SchoolClass of 2000
Certifications & Licensure
- MA State Medical License 2002 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Circulating RNAs in Acute Congestive Heart Failure Start of enrollment: 2016 Aug 17
Publications & Presentations
PubMed
- Multiparametric profiling of HER2-enriched extracellular vesicles in breast cancer using Single Extracellular VEsicle Nanoscopy.Nan Jiang, Andras Saftics, Eugenia Romano, Ima Ghaeli, Cristal Resto
Journal of Nanobiotechnology. 2024-09-28 - Clinical-transcriptional prioritization of the circulating proteome in human heart failure.Andrew S Perry, Kaushik Amancherla, Xiaoning Huang, Michelle L Lance, Eric Farber-Eger
Cell Reports. Medicine. 2024-09-17 - 1 citationsThe subcutaneous adipose transcriptome identifies a molecular signature of insulin resistance shared with visceral adipose.Mona Mashayekhi, Quanhu Sheng, Samuel S Bailin, Lucas Massier, Jiawei Zhong
Obesity. 2024-08-01
Press Mentions
- Proteomic Signature a Key to Early Detection of Fatty Liver Disease: StudyDecember 19th, 2024
- Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsSeptember 8th, 2022
- LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds De Solidarité FTQ to Accelerate Research of New Therapies for Long QT SyndromeJanuary 8th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: